Alyssa Flores is a senior commercial executive known for building and scaling revenue platforms for emerging and growth-stage medical technologies. With a strong foundation in high-performance medical sales and market access, she has consistently transformed early-stage innovations into commercially viable, revenue-generating businesses.
As Chief Commercial Officer, Alyssa leads enterprise-level commercialization strategy across the United States, with direct oversight of distribution architecture, channel expansion, and strategic partnerships. Her expertise spans durable medical equipment (DME), hospital systems, group purchasing organizations (GPOs), and government contracting—where she has successfully penetrated complex, high-barrier markets and established defensible revenue channels.
Alyssa is particularly recognized for structuring and executing high-impact commercial frameworks, including exclusive distribution models, government and institutional access strategies, and scalable go-to-market systems. She brings a disciplined approach to aligning clinical value with reimbursement pathways, ensuring that innovation translates into sustainable, repeatable revenue.
Her experience includes launching and scaling advanced wound care, biologics, and AI-driven technologies, with a focus on accelerating adoption while optimizing margin and long-term market positioning. She operates at the intersection of strategy and execution—building infrastructure that supports rapid growth while maintaining control over key revenue streams.
In addition to her executive leadership, Alyssa serves as a strategic advisor to medtech founders and investors, guiding commercialization strategy, deal structuring, and U.S. market entry. She is frequently engaged in opportunities where strong commercial leadership is required to unlock valuation and drive scale.
Alyssa is known for her decisive leadership style, sharp negotiation strategy, and ability to create alignment across stakeholders—consistently delivering results in competitive and complex healthcare environments.
